MONITORING AHENCY REPORT FOR THE YEAR ENDED 31ST MARCH 2026
JGCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
J.G. Chemicals filed its Q4 FY2026 Monitoring Agency Report (issued by ICRA Limited) for its March 2024 IPO. The IPO raised ₹251.19 crore (net proceeds ₹149.32 crore), with ₹131.47 crore deployed so far and ₹33.53 crore still unutilized. Of this, ₹4.26 crore is earmarked for setting up an R&D Centre (civil/construction work is ongoing), and ₹12.01 crore for long-term working capital. The company proposes to deploy ₹42.62 million of unutilized funds in FY2027 for R&D Centre capex, pending shareholder approval. ICRA flagged that R&D Centre purchases do not align with the vendor specifications in the prospectus, though the company cited management flexibility in equipment deployment. No material deviations were observed overall, and all objects are on schedule.
The unutilized IPO funds and the monitoring agency's note about vendor specification deviations are low-priority concerns, but investors should note the delayed R&D Centre spending and the proposed re-deployment of ₹42.62 million to FY2027.